GLP-1 Therapies and Risk of Muscle Loss Glucagon-like peptide-1 (GLP-1) medications have increasingly been prescribed to treat cardiometabolic conditions such as obesity, diabetes, and cardiovascular diseasesYeo et al (2024) conducted a nationwide analysis on the usage of GLP-1's in patients without diabetes and observed a 700% (from 21,000 in 2019 to 174,000 in 2023) increase between the years 2019-2023
ROS homeostasis plays a vital role in organismal balance and physiological processes [100]
She is ecstatic at her improvement on oral minoxidil
A history of recurrent and persistent lesions (at least two episodes in six months) is also helpful
We are living in what can accurately be called the patient experience economy. Patients now evaluate their care across five critical touch points: awareness, onboarding, daily use, support, and long-term outcome
Following a systematic approach to injection site management prevents any permanent skin or tissue changes